jump to navigation

Guest Blogger: Boston AF Symposium Highlights January 27, 2012

Posted by Heart Rhythm Society in Atrial Fibrillation (AF), Science & Research.
Tags: , , ,
add a comment

Editor’s Note: Guest blogger Hugh Calkins, MD, FHRS, CCDS is the Heart Rhythm Scientific Sessions Program Committee Chair (2012). He provides a brief overview of the Boston AF Symposium, which took place January 12 – 14, 2012.

This year’s Boston AF Symposium was very well attended, with more than 1,200 participants. I would like to share a few highlights from the meeting: (more…)

Guest Blogger: Atrial Fibrillation and Stroke – Education for the Public September 28, 2011

Posted by Heart Rhythm Society in Atrial Fibrillation (AF), Education.
Tags: , , , , ,
1 comment so far

Editor’s Note: Guest blogger Aman Chugh, MD, is an assistant professor in the Division of Cardiology, University of Michigan. In his post, he aims to educate the public about atrial fibrillation and its relation to stroke.

Although atrial fibrillation (AF) is usually not a life threatening arrhythmia, it may still result in significant morbidity. It is a major cause of stroke, accounting for approximately 20% of all strokes. (more…)

August EP News: Basic and Translational August 8, 2011

Posted by Peng-Sheng Chen, MD, FHRS in Science & Research.
Tags: , , ,
add a comment

Structure and function of sodium channels

Many voltage-gated ion channel (VGIC) superfamily members contain six-transmembrane segments in which the first four form a voltage-sensing domain (VSD) and the last two form the pore domain (PD).

Studies of potassium channels from the VGIC superfamily together with identification of voltage-sensor only proteins have suggested that the VSD and the PD can fold independently. Whether such transmembrane modularity is common to other VGIC superfamily members has remained untested. (more…)

HRS Update: FDA Issues Alert on the Heart Drug Multaq (dronedarone) July 22, 2011

Posted by Heart Rhythm Society in EP Physicians, Science & Research.
Tags: , , , , , ,
add a comment

The U.S. Food and Drug Administration (FDA) is reviewing data from the Permanent Atrial Fibrillation Outcome Study Using Dronedarone on Top of Standard Therapy (PALLAS)  study that was evaluating the effects of the antiarrhythmic drug Multaq (dronedarone) in patients with permanent atrial fibrillation. (more…)

HRS Offers Complimentary AF Awareness Resource Kit June 24, 2011

Posted by Heart Rhythm Society in Atrial Fibrillation (AF).
Tags: , , ,
add a comment

Looking ahead to National Atrial Fibrillation Awareness Month in September, the Heart Rhythm Society has created complimentary AF Awareness Resource Kits.  The kits contain materials to increase patients’ knowledge about AF risk factors, symptoms, and available treatment options.  The kits include the “A-Fib Feels Like” poster, CHADS2 Scorecard, Practical Rate & Rhythm Management of Atrial Fibrillation Pocket Guide, patient education brochures, and more. 

Physicians and caregivers can complete and submit the online order form and visit the Society’s website for AF education opportunities and additional resources.

Let us know in the comment section below if there are other items that would help you discuss Afib with your patients.

Help Publicize Our New AF Awareness PSA! June 16, 2011

Posted by Heart Rhythm Society in Atrial Fibrillation (AF), Society News.
Tags: , , , ,
add a comment

The Heart Rhythm Society kicked off its national Atrial Fibrillation Awareness Campaign with a new public service announcement (PSA), “A-Fib Feels Like.”

Please help publicize this important message by including the PSA on the website where you work, on your own blog or your social media profiles.

In addition, if you have strong relationships with television and/or radio affiliates in your area,  please contact Kennesha Baldwin, Manager of Media & Public Relations to learn how you can help bring attention to the PSA.

Finally, if you haven’t done so already, please view the PSA and tell us what you think!

Basic and Translational Research from Heart Rhythm Journal March 23, 2011

Posted by Peng-Sheng Chen, MD, FHRS in Science & Research.
Tags: ,
add a comment

Autonomic Denervation with Magnetic Nanoparticles

 Ganglionated plexi (GP) are important in the initiation of atrial fibrillation. Yu et al (Circulation 2010;122:2653, PMID: 21135360) reported a new method of autonomic denervation using nanoparticles. The authors synthesized superparamagnetic nanoparticles (MNPs) made of Fe3O4 (core), thermoresponsive polymeric hydrogel (shell), and neurotoxic agent (N-isopropylacrylamide monomer [NIPA-M]). (more…)

Guest Blogger – New Horizons in AF Management February 14, 2011

Posted by Heart Rhythm Society in Atrial Fibrillation (AF), Society News.
Tags: , ,
1 comment so far

Today, the ACCF/AHA/HRS issued an update to the atrial fibrillation (AF) guidelines with recommendations for the use of dabigatran, a recently approved agent by the U.S. Food and Drug Administration (FDA), which is a direct thrombin inhibitor and indicated for the prevention of stroke in AF. (more…)

Guest Blogger – New AF Guidelines: What’s the Buzz About? December 23, 2010

Posted by Heart Rhythm Society in Atrial Fibrillation (AF), Society News.
Tags: ,
2 comments

At long last, the ACCF/AHA/HRS 2011 Focused Update on Management of Patients with Atrial Fibrillation (AF) is available. In addition to this new guidance, I recommend that everyone review the 2006 Guidelines for the Management of Patients with AF and the  European Society of Cardiology’s Guidelines for the management of atrial fibrillation, as well.  (more…)

Updated AF Pocket Guide March 26, 2010

Posted by Heart Rhythm Society in Atrial Fibrillation (AF).
Tags: , ,
add a comment

Don’t miss the updated Practical Rate and Rhythm Management of Atrial Fibrillation Pocket Guide, adapted from the ACC/AHA/ESC 2006 Guidelines (825 KB PDF) as part of the Heart Rhythm Society’s AF 360° disease state initiative.

The guide includes information on:

  • General Approaches to the Patient with AF
  • Stroke Prevention in Patients with AF
  • Ventricular Rate Control
  • Restoration of Sinus Rhythm
  • Maintenance of Sinus Rhythm
  • Catheter Ablation
  • Dosing Guidelines for Drugs Commonly Used to Treat AF

Download and print a copy of the guide for free (1.15 MB PDF) or order (60 KB PDF) brochure-quality copies suitable for distribution among staff.

Follow

Get every new post delivered to your Inbox.